关注
Gianluca Veggiani
Gianluca Veggiani
在 lsu.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Programmable polyproteams built using twin peptide superglues
G Veggiani, T Nakamura, MD Brenner, RV Gayet, J Yan, CV Robinson, ...
Proceedings of the National Academy of Sciences 113 (5), 1202-1207, 2016
3402016
SpyLigase peptide–peptide ligation polymerizes affibodies to enhance magnetic cancer cell capture
JO Fierer, G Veggiani, M Howarth
Proceedings of the National Academy of Sciences 111 (13), E1176-E1181, 2014
2062014
Mutations and evolution of the SARS-CoV-2 spike protein
N Magazine, T Zhang, Y Wu, MC McGee, G Veggiani, W Huang
Viruses 14 (3), 640, 2022
1562022
Superglue from bacteria: unbreakable bridges for protein nanotechnology
G Veggiani, B Zakeri, M Howarth
Trends in biotechnology 32 (10), 506-512, 2014
1452014
Improved quantitative and qualitative production of single-domain intrabodies mediated by the co-expression of Erv1p sulfhydryl oxidase
G Veggiani, A de Marco
Protein expression and purification 79 (1), 111-114, 2011
842011
Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies
S Djender, A Schneider, A Beugnet, R Crepin, KE Desrumeaux, ...
Microbial cell factories 13, 1-10, 2014
812014
SpyAvidin hubs enable precise and ultrastable orthogonal nanoassembly
M Fairhead, G Veggiani, M Lever, J Yan, D Mesner, CV Robinson, ...
Journal of the American Chemical Society 136 (35), 12355-12363, 2014
792014
Emerging drug development technologies targeting ubiquitination for cancer therapeutics
G Veggiani, MCR Gerpe, SS Sidhu, W Zhang
Pharmacology & therapeutics 199, 139-154, 2019
612019
Whole-cell biopanning with a synthetic phage display library of nanobodies enabled the recovery of follicle-stimulating hormone receptor inhibitors
R Crepin, G Veggiani, S Djender, A Beugnet, F Planeix, C Pichon, ...
Biochemical and biophysical research communications 493 (4), 1567-1572, 2017
262017
Structural and functional characterization of a ubiquitin variant engineered for tight and specific binding to an alpha‐helical ubiquitin interacting motif
N Manczyk, BP Yates, G Veggiani, A Ernst, F Sicheri, SS Sidhu
Protein Science 26 (5), 1060-1069, 2017
252017
Single-domain antibodies that compete with the natural ligand fibroblast growth factor block the internalization of the fibroblast growth factor receptor 1
G Veggiani, G Ossolengo, M Aliprandi, U Cavallaro, A de Marco
Biochemical and Biophysical Research Communications 408 (4), 692-696, 2011
232011
Cholesterol loading and ultrastable protein interactions determine the level of tumor marker required for optimal isolation of cancer cells
J Jain, G Veggiani, M Howarth
Cancer research 73 (7), 2310-2321, 2013
222013
Engineered SH2 domains with tailored specificities and enhanced affinities for phosphoproteome analysis
G Veggiani, H Huang, BP Yates, J Tong, T Kaneko, R Joshi, SSC Li, ...
Protein Science 28 (2), 403-413, 2019
162019
Comparative analysis of fusion tags used to functionalize recombinant antibodies
G Veggiani, B Giabbai, MS Semrau, B Medagli, V Riccio, G Bajc, P Storici, ...
Protein Expression and Purification 166, 105505, 2020
152020
The ubiquitin interacting motifs of USP37 act on the proximal Ub of a di-Ub chain to enhance catalytic efficiency
N Manczyk, G Veggiani, J Teyra, AW Strilchuk, SS Sidhu, F Sicheri
Scientific Reports 9 (1), 4119, 2019
122019
Transmembrane protein rotaxanes reveal kinetic traps in the refolding of translocated substrates
J Feng, P Martin-Baniandres, MJ Booth, G Veggiani, M Howarth, H Bayley, ...
Communications Biology 3 (1), 159, 2020
112020
Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands
EM Linossi, K Li, G Veggiani, C Tan, F Dehkhoda, C Hockings, DJ Calleja, ...
Nature Communications 12 (1), 7032, 2021
92021
Dimerization of a ubiquitin variant leads to high affinity interactions with a ubiquitin interacting motif
N Manczyk, G Veggiani, GD Gish, BP Yates, A Ernst, SS Sidhu, F Sicheri
Protein Science 28 (5), 848-856, 2019
92019
Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis
J Zuin, G Veggiani, P Pengo, A Gallotta, A Biasiolo, N Tono, A Gatta, ...
Clinical chemistry and laboratory medicine 48 (2), 217-223, 2010
92010
High-affinity chromodomains engineered for improved detection of histone methylation and enhanced CRISPR-based gene repression
G Veggiani, R Villaseñor, GD Martyn, JQ Tang, MW Krone, J Gu, C Chen, ...
Nature Communications 13 (1), 6975, 2022
82022
系统目前无法执行此操作,请稍后再试。
文章 1–20